ZA49 (Mycophenolate mofetil 500 mg)

Pill imprint ZA49 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; multiple sclerosis; organ transplant, rejection prophylaxis; autoimmune hepatitis; dermatomyositis (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ZA49

Mycophenolate mofetil 500 mg ZA49
Mycophenolate mofetil 500 mg ZA49
Mycophenolate mofetil
Imprint:
ZA49
Strength:
500 mg
Color:
White
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0131
Inactive Ingredients:
croscarmellose sodium
hypromelloses
magnesium stearate
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
microcrystalline cellulose
silicon dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)